Laboratory testing for secondary osteoporosis evaluation

被引：15

作者：

Adler, Robert A. ^{[1
]}

机构：

[1] Virginia Commonwealth Univ, McGuire Vet Affairs Med Ctr, Dept Internal Med,Dept Epidemiol & Community Hlth, Endocrinol & Metab Sect,Sch Med, Richmond, VA 23249 USA

来源：

CLINICAL BIOCHEMISTRY | 2012年 / 45卷 / 12期

关键词：

Osteoporosis; Hypogonadism; Glucocorticoids; Hyperparathyroidism; Inflammatory bowel disease; Celiac disease; Biliary cirrhosis; Rheumatoid arthritis; Chronic Obstructive Pulmonary Disease; BONE-MINERAL DENSITY; VITAMIN-D DEFICIENCY; GLUCOCORTICOID-INDUCED OSTEOPOROSIS; GROWTH-FACTOR-I; IDIOPATHIC OSTEOPOROSIS; CELIAC-DISEASE; 25-HYDROXYVITAMIN D; MULTIPLE-MYELOMA; FRACTURE RISK; MEN;

D O I：

10.1016/j.clinbiochem.2012.01.024

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Osteoporosis has been classified into primary and secondary forms. All patients with osteoporosis should have measurements of 25-hydroxyvitamin D, serum and urine calcium, and some estimation of renal function. There are a wide variety of disorders that lead to secondary osteoporosis, and the tests that confirm these diagnoses are described herein. Making the specific diagnosis is important because treatment of the underlying condition may be sufficient to lessen fracture risk, although some patients may also need usual treatment for osteoporosis. Laboratory testing in addition to a careful history and physical examination will often lead to diagnoses of treatable conditions. (C) 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

引用

页码：894 / 900

页数：7

共 62 条

[1]

Adler RA, 2011, J ENDOCRINOL INVEST, V34, P481, DOI [10.1007/BF03346716, 10.3275/7753]

[2] Glucocorticoid-induced osteoporosis in patients with sarcoidosis [J].